Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

MicroRNA-1 overexpression blunts cardiomyocyte hypertrophy elicited by thyroid hormone

Full text
Author(s):
Diniz, Gabriela Placona ; Lino, Caroline Antunes ; Moreno, Camila Rodrigues ; Senger, Nathalia ; Morais Barreto-Chaves, Maria Luiza
Total Authors: 5
Document type: Journal article
Source: Journal of Cellular Physiology; v. 232, n. 12, p. 3360-3368, DEC 2017.
Web of Science Citations: 6
Abstract

It is well-known that increased thyroid hormone (TH) levels induce cardiomyocyte growth. MicroRNAs (miRNAs) have been identified as key players in cardiomyocyte hypertrophy, which is associated with increased risk of heart failure. In this study, we evaluated the miR-1 expression in TH-induced cardiac hypertrophy, as well as the potential involvement of miR-1 in cardiomyocyte hypertrophy elicited by TH in vitro. The possible role of type 1 angiotensin II receptor (AT1R) in the effect promoted by TH in miR-1 expression was also evaluated. Neonatal rat cardiac myocytes (NRCMs) were treated with T-3 for 24 hr and Wistar rats were subjected to hyperthyroidism for 14 days combined or not with AT1R blocker. Real Time RT-PCR analysis indicated that miR-1 expression was decreased in cardiac hypertrophy in response to TH in vitro and in vivo, and this effect was unchanged by AT1R blocker. In addition, HDAC4, which is target of miR-1, was increased in NRCMs after T-3 treatment. A gain-of-function study revealed that overexpression of miR-1 prevented T-3-induced cardiomyocyte hypertrophy and reduced HADC4mRNA levels in NRCMs. In vivo experiments confirmed the downregulation of miR-1 in cardiac tissue from hyperthyroid animals, which was accompanied by increased HDAC4 mRNA levels. In addition, HDAC inhibitor prevented T-3-induced cardiomyocyte hypertrophy. Our data reveal a new mechanistic insight into cardiomyocyte growth in response to TH, suggesting that miR-1 plays a role in cardiomyocyte hypertrophy induced by TH potentially via targeting HADC4. (AU)

FAPESP's process: 09/14567-7 - Analysis of microRNAs expression on cardiac hypertrophy induced by thyroid hormone, "in vivo" and "in vitro". role of AT1 receptor
Grantee:Gabriela Placoná Diniz
Support Opportunities: Scholarships in Brazil - Post-Doctoral